{"id":48,"date":"2015-10-21T11:16:15","date_gmt":"2015-10-21T10:16:15","guid":{"rendered":"http:\/\/blog.u-bourgogne.fr\/list-maps\/?page_id=48"},"modified":"2016-06-03T09:15:44","modified_gmt":"2016-06-03T08:15:44","slug":"genxpro","status":"publish","type":"page","link":"https:\/\/blog.ube.fr\/list-maps\/consortium\/beneficiaries\/genxpro\/","title":{"rendered":"GenXPro"},"content":{"rendered":"

\"genxprologo\"<\/a><\/p>\n

PRESENTATION OF THE COMPANY<\/strong><\/p>\n

GenXPro is specialized in Next-Generation-Sequencing (NGS) based analysis and bioinformatics. Founded in 2005, we have developed a broad spectrum of techniques and methods based on NGS and provide a full service, including bioinformatics statistical analyses and presentation of the data. Our service portfolio also includes metagenomics and metatranscriptomics. In 2008 we have invented the \u201cTrueQuant\u201d method, which is based on barcoding each DNA-molecule prior to PCR amplification. As each barcode-template combination is statistically unique, PCR-duplicates can be identified and eliminated from the dataset to prevent PCR-bias. Our customers are from all fields of life sciences but mainly from agro- and medical institutions and companies worldwide. Recently, we are concentrating our efforts to offer services for precision medicine in cancer treatment. This year we have launched a transcriptome sequencing kit based on our TrueQuant method for high resolution gene expression analysis and low-bias data called \u201cMACE\u201d (Massive Analysis of cDNA Ends).<\/p>\n

Website:<\/strong> http:\/\/genxpro.info\/about_us\/<\/a><\/p>\n

ROLE IN THE PROJECT<\/strong><\/p>\n

Sub-project 10: Development of bioinformatics tools for the analysis of MACE data<\/a><\/p>\n

Sub-project 11: Development of innovative tools for rapid phenotypic characterisation of intraspecific diversity<\/a><\/p>\n

STAFF INVOLVED<\/strong><\/p>\n

\u00a0 Bj\u00f6rn ROTTER<\/strong><\/p>\n

\u00a0\"photo<\/a><\/strong><\/p>\n

Education<\/strong><\/p>\n